Novo expects Victoza and semaglutide to gain momentum.
Novo hopes data will justify higher price compared with rival.
Semaglutide is under review in Europe and US.
Dexcom G5 Mobile data will be displayed on Fitbit’s Ionic smartwatch.
Device combination capable of recommending treatment decisions without finger-pricking.
While many of the hopes and disappointments for AZ’s business are around oncology, it still needs its cardiovascular and diabetes portfolio to perform.
Trial will test Tandem’s t:slim X2 pump alongside a predictive algorithm.